Available
Project number:
2025_17
Start date:
October 2025
Project themes:
Main supervisor:
Senior Lecturer in Bioinformatics
Co-supervisor:
Dr Giorgio Napolitani, Senior Lecturer at Comprehensive Cancer Centre
Additional Information:
Towards finding clinical and immunological signatures from a heterogeneous and multimodal clonal haematopoiesis data
Background Clonal haematopoiesis (CH), a condition found in at least 30% of healthy elderlies, is associated with increased mortality. In CH, there is an age-associated acquisition of mutations in haematopoietic stem and progenitor cells (HSPCs). Inflammatory-microenvironment (IM) provides expansive advantages to mutant clones in CH, and age-associated inflammation (inflammaging) plays a key role in IM development. Moreover, somatic mutations can also alter the immune microenvironment, resulting in escape from the body's immune surveillance. We have recently collected human bone marrow and blood samples from 730 healthy patients over the age of 50. We have also collected comprehensive clinical, genetic, proteomic, and immunology information for these patients. Novelty & Importance Understanding the interplay between the immune environment and CH might help to identify the mechanisms underpinning the increased risk of developing inflammatory diseases associated with CH. To the best of our knowledge this is the largest dataset generated including data on mutations associated with CH, plasma proteomic profiling, and detailed clinical information. Multimodal integrative analysis of this dataset might reveal therapeutic targets and biomarkers to tackle both the cause and the consequences of clonal haematopoiesis. Aims & Objectives Aim 1: Integrative analysis of multimodal CH data to identify the biological and clinical signatures of CH and CH subtypes Aim 2: Identification of biological factors explaining clonal expansion in CH cases with follow-up data Aim 3: Develop an integrative analysis pipeline and apply that to publicly available data for CH and validate the outcome from our local CH cohort
We are now accepting applications for 1 October 2025
How to apply
Candidates should possess or be expected to achieve a 1st or upper 2nd class degree in a relevant subject including the biosciences, computer science, mathematics, statistics, data science, chemistry, physics, and be enthusiastic about combining their expertise with other disciplines in the field of healthcare.
Important information for International Students:
It is the responsibility of the student to apply for their Student Visa. Please note that the EPSRC DRIVE-Health studentship does not cover the visa application fees or the Immigration Health Surcharge (IHS) required for access to the National Health Service. The IHS is mandatory for anyone entering the UK on a Student Visa and is currently £776 per year for each year of study. Further detail can be found under the International Students tab below.
Next Steps
- Applications submitted by the closing date of Thursday 6 February 2025 will be considered by the CDT. We will contact shortlisted applicants with information about this part of the recruitment process.
- Candidates will be invited to attend an interview. Interviews are projected to take place in April 2025.
- Project selection will be through a panel interview chaired by either Professor Richard Dobson and Professor Vasa Curcin (CDT Directors) followed by informal discussion with prospective supervisors.
- If you have any questions related to the specific project you are applying for, please contact the main supervisor of the project directly.
For any other questions about the recruitment process, please email us at